Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C20401
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/16/1756
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
||
|
WHO-ATC |
L01XC25
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
||
|
FDA ORPHAN DRUG |
322010
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
||
|
FDA ORPHAN DRUG |
345311
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
||
|
FDA ORPHAN DRUG |
313710
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL1743041
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
2054077
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
ALTERNATIVE | |||
|
1159266-37-1
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
5031
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
YI437801BE
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
100000139237
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
YI437801BE
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
POTELIGEO
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | APPROVED MARCH 2012 | ||
|
m11705
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
Mogamulizumab
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
MOGAMULIZUMAB
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
9374
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL2109340
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
2054068
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
C62510
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
SUB85518
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
6477
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
XX-20
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
SUB77002
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY | |||
|
DB12498
Created by
admin on Mon Mar 31 20:09:37 GMT 2025 , Edited by admin on Mon Mar 31 20:09:37 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
